The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
Open accessAbstract
There is a medical need for an agent with the positive effects of estrogen on bone and the cardiovascular system, but without the negative effects on reproductive tissue. Raloxifene (LY139481 HCI) is a benzothiophene derivative that binds to the estrogen receptor and inhibits the effects of estrogen on the uterus. In an ovariectomized (OVX) rat model we investigated the effects of raloxifene on bone loss (induced by estrogen deficiency), serum lipids, and uterine tissue. After oral administration of raloxifene for 5 wk (0.1-10 mg/kg per d) to OVX rats, bone mineral density in the distal femur and proximal tibia was significantly greater than that observed in OVX controls (ED50 of 0.03-0.3 mg/kg). Serum cholesterol was lower in the raloxifene-treated animals, which had a minimal effective dose of 0.1 mg/kg and an approximate oral ED50 of 0.2 mg/kg. The effects of raloxifene on bone and serum cholesterol were comparable to those of a 0.1-mg/kg per d oral dose of ethynyl estradiol. Raloxifene diverged dramatically from estrogen in its lack of significant estrogenic effects on uterine tissue. Ethynyl estradiol produced a marked elevation in a number of uterine histologic parameters (e.g., epithelial cell height, stromal eosinophilia). These data suggest that raloxifene has promise as an agent with beneficial bone and cardiovascular effects in the absence of significant uterine effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantitative Determination of Serum Triglycerides by the Use of Enzymes
Bucolo, G., & David, H. (1973) · Clinical Chemistry · doi:10.1093/clinchem/19.5.476 · Cited by 3,188
The ovariectomized rat model of postmenopausal bone loss
Kalu, D. N. (1991) · Bone and Mineral · doi:10.1016/0169-6009(91)90124-i · Cited by 1,361
Walsh, B. W., Schiff, I., Rosner, B., Greenberg, L., Ravnikar, V., & Sacks, F. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110243251702 · Cited by 1,152
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
Love, R. R., Mazess, R. B., Barden, H. S., Epstein, S., Newcomb, P. A., Jordan, V. C., Carbone, P. P., & DeMets, D. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261302 · Cited by 1,129
Menopause and Risk Factors for Coronary Heart Disease
Matthews, K. A., Meilahn, E., Kuller, L. H., Kelsey, S. F., Caggiula, A. W., & Wing, R. R. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909073211004 · Cited by 1,040
Menopause and Coronary Heart Disease: The Framingham Study
GORDON, T., KANNEL, W. B., HJORTLAND, M. C., & McNAMARA, P. M. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-2-157 · Cited by 888
Windler, E. E., Kovanen, P. T., Chao, Y. S., Brown, M. S., Havel, R. J., & Goldstein, J. L. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70487-6 · Cited by 457
Overgaard, K., Hansen, M. A., Jensen, S. B., & Christiansen, C. (1992) · BMJ · doi:10.1136/bmj.305.6853.556 · Cited by 426
The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats
Seedor, J. G., Quartuccio, H. A., & Thompson, D. D. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060405 · Cited by 407
Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal Women
Love, R. R., Wiebe, D. A., Newcomb, P. A., Cameron, L., Leventhal, H., Jordan, V. C., Feyzi, J., & DeMets, D. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-11-860 · Cited by 374
Estrogen Treatment Prevents Osteopenia and Depresses Bone Turnover in Ovariectomized Rats*
WRONSKI, T. J., CINTRON, M., DOHERTY, A. L., & DANN, L. M. (1988) · Endocrinology · doi:10.1210/endo-123-2-681 · Cited by 356
Effects of anti-estrogens on bone in castrated and intact female rats
Jordan, V. C., Phelps, E., & Lindgren, J. U. (1987) · Breast Cancer Research and Treatment · doi:10.1007/bf01806132 · Cited by 324
Hepatic catabolism of rat and human lipoproteins in rats treated with 17 alpha-ethinyl estradiol.
Chao, Y. S., Windler, E. E., Chen, G. C., & Havel, R. J. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86494-3 · Cited by 317
Symptoms Associated With Tamoxifen Treatment in Postmenopausal Women
Love, R. R. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400090120021 · Cited by 273
Hormonal Chemoprevention of Cancer in Women
Henderson, B. E., Ross, R. K., & Pike, M. C. (1993) · Science · doi:10.1126/science.8381558 · Cited by 239
Antagonism of estrogen action with a new benzothiophene derived antiestrogen
Black, L. J., Jones, C. D., & Falcone, J. F. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90935-9 · Cited by 239
Self-citationTURNER, R. T., WAKLEY, G. K., HANNON, K. S., & BELL, N. H. (1988) · Endocrinology · doi:10.1210/endo-122-3-1146 · Cited by 224
Ammann, P., Dr. Rizzoli, R., Slosman, D., & Bonjour, J.-P. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070310 · Cited by 215
Ma, P. T., Yamamoto, T., Goldstein, J. L., & Brown, M. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.3.792 · Cited by 192
Riggs, B. L. (1991) · PubMed Central · Cited by 173
Skeletal response of ovariectomized rats to low and high doses of 17β-estradiol
Kalu, D. N., Liu, C. C., Salerno, E., Hollis, B. W., Echon, R., & Ray, M. (1991) · Bone and Mineral · doi:10.1016/0169-6009(91)90021-q · Cited by 156
Pharmacology of tamoxifen in laboratory animals.
Jordan, V. C., Allen, K. E., & DIX, C. J. (1981) · PubMed · Cited by 142
Clomiphene protects against osteoporosis in the mature ovariectomized rat
Beall, P. T., Misra, L. K., Young, R. L., Spjut, H. J., Evans, H. J., & LeBlanc, A. (1984) · Calcified Tissue International · doi:10.1007/bf02405304 · Cited by 140
Dual-energy x-ray absorptiometry of the rat: Accuracy, precision, and measurement of bone loss
Griffin, M. G., Kimble, R. B., Hopfer, W., & Pacifici, R. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080704 · Cited by 131
Estrogen Replacement Therapy: Indications and Complications
Judd, H. L., MELDRUM, D. R., DEFTOS, L. J., & Henderson, B. E. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-2-195 · Cited by 129
Turner, R. T., Evans, G. L., & Wakley, G. K. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080313 · Cited by 97
Staels, B., Auwerx, J. H., Chan, L., van Tol, A., Rosseneu, M., & Verhoeven, G. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38272-9 · Cited by 94
Skeletal Effects of Calcitonin in Ovariectomized Rats*
Wronski, T. J., Yen, C. ‐., BURTON, K. W., Mehta, R., Newman, P. S., Soltis, E. E., & DeLuca, P. P. (1991) · Endocrinology · doi:10.1210/endo-129-4-2246 · Cited by 72
Symptoms associated with tamoxifen treatment in postmenopausal women
Love, R. R. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.9.1842 · Cited by 70
Dose-Dependent Effects of Tamoxifen on Long Bones in Growing Rats: Influence of Ovarian Status*
MOON, L. Y., Wakley, G. K., & Turner, R. T. (1991) · Endocrinology · doi:10.1210/endo-129-3-1568 · Cited by 65
FROMM, G. A., Vega, E., Plantalech, L., Galich, A. M., & Mautalén, C. (1991) · Osteoporosis International · doi:10.1007/bf01625440 · Cited by 62
Menopause and Coronary Heart Disease. The Framingham Study
Gordon, T., Kannel, W. B., Hjortland, M. C., & MCNAMARA, P. M. (1979) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-197903000-00020 · Cited by 55
WALKER, B. W., Schiff, I., ROSNER, B. A., Greenberg, L., Ravnikar, V. A., & Sacks, F. M. (1992) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199203000-00024 · Cited by 48
Evaluating the benefits and risks of postmenopausal hormone therapy
Cummings, S. R. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90241-o · Cited by 37
Menopause and risk factors for coronary heart disease
Matthews, K. A., Meilahn, E. N., Kuller, L. H., Kelsey, S. F., Caggiula, A. W., & Wing, R. R. (1990) · Maturitas · doi:10.1016/0378-5122(90)90095-n · Cited by 31
Cited by
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
Cummings, S. R., Eckert, S., Krueger, K. A., Grady, D., Powles, T. J., Cauley, J. A., Norton, L., Nickelsen, T., Bjarnason, N. H., Morrow, M., et al. (1999) · JAMA · doi:10.1001/jama.281.23.2189 · Cited by 1,872
Delmas, P. D., Bjarnason, N. H., Mitlak, B. H., Ravoux, A.-C., Shah, A. S., Huster, W. J., Draper, M., & Christiansen, C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712043372301 · Cited by 1,637
The worldwide problem of osteoporosis: Insights afforded by epidemiology
Riggs, B. L., & Melton, L. J. (1995) · Bone · doi:10.1016/8756-3282(95)00258-4 · Cited by 1,404
Lamberts, S. W. J., van den Beld, A. W., & van der Lely, A.-J. (1997) · Science · doi:10.1126/science.278.5337.419 · Cited by 980
Metadata
- Authors
- Black, L. J., Sato, M., Rowley, E. R., Magee, D. E., Bekele, A., Williams, D. C., Cullinan, G. J., Bendele, R., Kauffman, R. F., & Bensch, W. R.
- Venue
- Journal of Clinical Investigation
- Published
- 1994-01-01
- Volume
- 93
- Issue
- 1
- Pages
- 63-69
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2008039212
- Cited by
- 609
- References
- 35
- FWCI
- 20.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.